PRNewsWire - Health - Latest News Search Engine - Global and Local Breaking News

PRNewsWire - Health

Accord Healthcare erhält die Zulassung für Hetronifly® (Serplulimab) von der Medicines and Healthcare Regulatory Agency (MHRA) für die Erstlinienbehan...

Intas und seine Tochtergesellschaft Accord Healthcare leiten die Vermarktung in Europa und Indien. Im Dezember 2022 erhielt Serplulimab von der Europä...

Accord Healthcare erhält die Zulassung für Hetronifly® (Serplulimab) von der Medicines and Healthcare Regulatory Agency (MHRA) für die Erstlinienbehandlung von kleinzelligem Lungenkrebs im Extensivstadium (ES-SCLC)

Accord Healthcare receives approval for Hetronifly® (Serplulimab), from the Medicines and Healthcare Regulatory Agency (MHRA) for first-line treatment...

Intas and its subsidiary Accord Healthcare lead commercialisation in Europe and India. In December 2022, serplulimab received orphan drug designation ...

Accord Healthcare receives approval for Hetronifly® (Serplulimab), from the Medicines and Healthcare Regulatory Agency (MHRA) for first-line treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

TKSoftware Inc. Unveils ICONIC Pro: The All-In-One Medical Billing & Clearinghouse Solution

TKSoftware Inc. today launches ICONIC Pro, a unified, cloud–based platform that combines claims submission, electronic remittance, eligibility verific...

TKSoftware Inc. Unveils ICONIC Pro: The All-In-One Medical Billing & Clearinghouse Solution

Pals Health Redefines Supplement Standards with Clinically Proven Ingredients and Exceptional Bioavailability

TOMS RIVER, N.J., June 20, 2025 /PRNewswire/ -- In a supplement market saturated with empty promises and low-quality formulations, Pals Health emerges...

Pals Health Redefines Supplement Standards with Clinically Proven Ingredients and Exceptional Bioavailability